Nawal Ouzren

Chief Executive Officer

With 15 years of experience in operational and strategic management within the pharmaceutical industry, Mrs. Ouzren started out at Baxter, where she was Strategy and Operational Excellence Manager, Quality Operations Director and Senior Director Strategy before becoming Vice President of the BioSimilars business unit. In 2014, she became Vice President of the Global Hemophilia Franchise at Baxalta, which had been incorporated within the Shire group. In 2016, she headed up the Global Genetic Diseases Franchise at Shire, where she supervised all marketing, business and strategy aspects of this global division’s product portfolio.

nawal ouzren

Géraldine Honnet

Chief Medical Officer

Géraldine Honnet is a Medical Doctor who received her diploma from Necker Enfants-malades Hospital (Children’s hospital) in 1996 and worked during 5 years as Clinical Research Physician and Investigator for the ANRS (French Agency for the Fight against AIDS) and the clinical trials for the pharmaceutical industry. After that, Géraldine worked as a Medical Director at clinical research organization Parexel International from 2001 to 2005 and then as International Project Manager for Janssen-Cilag (Johnson & Johnson) before joining biotech company Transgene in 2007, where she was responsible for the clinical development of gene therapy products for infectious diseases. Before joining Sensorion, Géraldine worked at Généthon from 2011 to January 2020 as Chief Medical Officer, overseeing international gene therapy clinical trials in multiple rare diseases. She was responsible for the development of Généthon pipeline from pre-clinical to registration, managing Medical Affairs, Clinical Development, Clinical Operations and Regulatory Affairs departments.

 geraldine Honnet

Juergen Heitmann

Chief Business Officer

Juergen Heitmann, a biologist by training with a PhD from the University of Tübingen where he already worked in the inner ear field. Juergen started his professional career in the medical device industry at Biotronik and as a Senior Consultant at McKinsey & Co. He then spent more than 20 years in the pharmaceutical industry in various Business Development roles at Novartis, Nycomed and Takeda. More recently he advised Venture Capital and Biotech companies on Corporate Development and Strategy topics. He started working for Sensorion in 2017 first as a consultant and since September 2019 as the Chief Business Officer. 

 Julien Miara

Judith Laredo, PhD

Clinical Research Director

Judith Laredo is an experienced professional with extensive skills in drug development gained over 20 years in pharma and biotech environments. She held different positions in clinical development at Servier Laboratories, starting with clinical trial management, translational research then as Head of Department in Psychiatry. Her expertise in clinical development strategy and study design ranges from proof of concept to phase 3 studies. In 2014, she became Alliance Manager in the Oncology department where she has been in charge of several alliance programs in cell therapy and immunotherapy. She holds a PhD in Pharmacology and Toxicology from the University of Toulouse followed by a Master of Science in Management from Aix-Marseille Graduate School of Management

judith laredo








20200910 pipeline


Corporate presentation